Tiny study hopes to simplify muscle testing for rare muscle disease

NCT ID NCT05027152

Completed Knowledge-focused Sponsor: Federal University of Espirito Santo Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at a new way to measure muscle function in people with inflammatory myopathies (diseases that cause muscle weakness). Researchers compared a simple test called the Myositis Functional Index-3 with advanced computerised muscle testing. They also tested whether a repetitive task training program could help improve muscle strength and endurance. Only 2 people took part, so the results are very preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: repetitive task training
What this could lead to: If successful, this could provide a simpler, cheaper way to track muscle function in myositis and suggest that repetitive task training is safe and effective.
What could go wrong: This is a very small, early study with only 2 participants, so results may not apply to everyone. The training may not show clear benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DERMATOMYOSITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dermatomyositis idiopathic inflammatory myopathy Motor Activity myositis disease polymyositis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DERMATOMYOSITIS IDIOPATHIC INFLAMMATORY MYOPATHY POLYMYOSITIS

Contacts and locations

Locations

Samira Tatiyama Miyamoto, PhD

Vitória, Espírito Santo, 29050-780, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.